GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (OTCPK:KSPHF) » Definitions » Cyclically Adjusted PS Ratio

KSPHF (Kissei Pharmaceutical Co) Cyclically Adjusted PS Ratio : 2.71 (As of Jun. 01, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2025-06-01), Kissei Pharmaceutical Co's current share price is $27.13. Kissei Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was $10.02. Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 2.71.

The historical rank and industry rank for Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

KSPHF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.45   Med: 1.98   Max: 2.65
Current: 2.57

During the past years, Kissei Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 2.65. The lowest was 1.45. And the median was 1.98.

KSPHF's Cyclically Adjusted PS Ratio is ranked worse than
53.25% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs KSPHF: 2.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Kissei Pharmaceutical Co's adjusted revenue per share data for the three months ended in Dec. 2024 was $3.437. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $10.02 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 1.75 1.73 2.22 -

Kissei Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 2.03 2.18 2.50 -

Competitive Comparison of Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


;
;

Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=27.13/10.02
=2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kissei Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Kissei Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=3.437/110.7000*110.7000
=3.437

Current CPI (Dec. 2024) = 110.7000.

Kissei Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 2.970 97.900 3.358
201506 2.756 98.400 3.101
201509 2.878 98.500 3.234
201512 3.386 98.100 3.821
201603 3.175 97.900 3.590
201606 3.717 98.100 4.194
201609 3.349 98.000 3.783
201612 3.308 98.400 3.722
201703 3.134 98.100 3.537
201706 3.517 98.500 3.953
201709 3.314 98.800 3.713
201712 3.701 99.400 4.122
201803 3.436 99.200 3.834
201806 3.473 99.200 3.876
201809 3.402 99.900 3.770
201812 3.737 99.700 4.149
201903 3.282 99.700 3.644
201906 3.191 99.800 3.540
201909 3.075 100.100 3.401
201912 3.336 100.500 3.675
202003 2.919 100.300 3.222
202006 3.196 99.900 3.542
202009 3.289 99.900 3.645
202012 4.106 99.300 4.577
202103 3.332 99.900 3.692
202106 3.276 99.500 3.645
202109 3.101 100.100 3.429
202112 3.371 100.100 3.728
202203 2.797 101.100 3.063
202206 2.636 101.800 2.866
202209 2.509 103.100 2.694
202212 3.017 104.100 3.208
202303 2.573 104.400 2.728
202306 2.969 105.200 3.124
202309 2.607 106.200 2.717
202312 3.228 106.800 3.346
202403 2.672 107.200 2.759
202406 3.033 108.200 3.103
202409 3.371 108.900 3.427
202412 3.437 110.700 3.437

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kissei Pharmaceutical Co  (OTCPK:KSPHF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Kissei Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kissei Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co Headlines